Health & Nutrition
Pfizer CEO reveals 2030 growth plan as company faces up...
CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion...
J&J's nearly $17 billion offer to buy a heart pump maker...
Johnson & Johnson's (JNJ) $16.6 billion deal to buy heart pump maker Abiomed...
Pfizer RSV vaccine given to pregnant mothers is effective...
Pfizer said it will submit an application to the Food and Drug Administration for...
Long Covid is affecting women more than men, national survey...
More than 17% of women reported experiencing long Covid at some point during the...
Pfizer raises 2022 earnings guidance, beats third-quarter...
Pfizer now expects earnings per share of $6.40 to $6.50 for the year, up from its...
Treating Psoriasis with Aloe Vera
Psoriasis is a chronic, inflammatory skin disease that affects about one in 40 people,...
Multiple revenue misses in one of our winners convinced...
We never like to sell on a down day. But after an iffy quarter, we decided to exit.
We're exiting a drug stock for a nice gain and putting...
We continue to like health care as a defensive area of the market.
Omicron subvariants resistant to key antibody treatments...
The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant...
FDA says two studies showing omicron boosters weren't much...
The FDA pushed back against two independent studies that found the new boosters...
